This Tiny Tech Stock Is Quietly Building a Huge Business in Air Quality
Source: Matt Badiali for Streetwise Reports  (1/5/21)
Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic. More >

Biopharma Recaps 2020 Accomplishments in COVID-19, Idiopathic Pulmonary Disease
Source: Streetwise Reports  (1/4/21)
Algernon Pharmaceuticals reports that it is aggressively advancing its repurposed drug, Ifenprodil. More >

Biopharma Appoints Adviser for Phase 3 COVID-19 Trial
Source: Streetwise Reports  (1/4/21)
Revive Therapeutics selects Dr. John Fahy, California-based pulmonary medicine expert and researcher, to join its team. More >

Pandion Shares Get a Lift from Positive Top-Line Data in Phase 1a Autoimmune Disease Trial
Source: Streetwise Reports  (1/4/21)
Pandion Therapeutics shares traded 35% higher after the company reported positive top-line data from its Phase 1a clinical study of PT101 for treating autoimmune diseases including ulcerative colitis and systemic lupus erythematosus. More >

StrikePoint Gold: High-Grade Silver and Gold in the Golden Triangle
Source: Erik Wetterling aka "The Hedgeless Horseman" for Streetwise Reports  (1/4/21)
Erik Wetterling, aka "The Hedgeless Horseman," provides his investment thesis for StrikePoint Gold. More >

Gold Set to Soar as Hyperinflation Looms
Source: Clive Maund for Streetwise Reports  (1/4/21)
Technical analyst Clive Maund discusses the dollar's fall and what it means for gold. More >

Gold Is Still a Bargain
Source: Peter Krauth for Streetwise Reports  (1/4/21)
Peter Krauth discusses the confluence of factors that points to the gold bull market having plenty of upside ahead. More >

Silver: A Powerful Advance Believed Imminent
Source: Clive Maund for Streetwise Reports  (1/4/21)
Technical analyst Clive Maund charts silver and explains why he believes the metal is primed to move much higher. More >

ParcelPal, a Small-Cap DoorDash, Looks Set to Achieve Three Consecutive Months of Profitability
Source: Streetwise Reports  (1/4/21)
The fast growing company offers quick delivery in the areas it serves. More >

Firm Acquires Near-Term Producing NSR Royalty in Nevada, 'Offers an Attractive Growth Profile'
Source: Streetwise Reports  (12/31/20)
This latest transaction of Ely Gold Royalties is discussed in a Noble Capital Markets report. More >

Drill Results Show 'Potential Beyond Upcoming Maiden Resource'
Source: Streetwise Reports  (12/31/20)
These latest assays from Liberty Gold's Black Pine project are reviewed in a PI Financial report. More >

Intrepid Shares Grow 40% on Positive Upward Trend for 2021 Trio and Potash Prices
Source: Streetwise Reports  (12/31/20)
Shares of Intrepid Potash Inc. sprouted to a new 52-week high after the company reported that it anticipates greater demand and higher prices for its Trio and potash products in 2021. More >

California Biotech Advances Two COVID-19 Products
Source: Streetwise Reports  (12/30/20)
Recent news concerning Sorrento Therapeutics' SARS-CoV-2 virus test and antibodies is discussed in a Dawson James Securities report. More >

Biotech On Track for Trio of Drugs in Clinical Trials in 2021
Source: Streetwise Reports  (12/30/20)
The next steps for advancing Oramed Pharmaceuticals' oral therapy candidates are provided in an H.C. Wainwright & Co. report. More >

DermTech Shares Rise 32% on Geisinger Health Support for Skin Cancer Test
Source: Streetwise Reports  (12/30/20)
Shares of DermTech Inc. climbed to a new 52-week high after the company reported it has received positive medical coverage by Geisinger Health System for its pigmented lesion assay, a non-invasive test for detecting melanoma. More >

Technical Analyst: This Silver Stock Is About to Break Out
Source: Clive Maund for Streetwise Reports  (12/30/20)
Technical analyst Clive Maund charts Metallic Minerals and explains why he believes the stock is "now ready to break out to the upside." More >

U.S. Gold Miner Reports Game-Changing Drill Results
Source: Matt Badiali for Streetwise Reports  (12/30/20)
Independent financial analyst Matt Badiali delves into U.S. Gold's recent drill results at the CK Gold Deposit in Wyoming. More >

Phase 3 COVID-19 Trial on Track for Independent Safety, Efficacy Review
Source: Streetwise Reports  (12/29/20)
Revive Therapeutics plans to apply for emergency use authorization of its drug Bucillamine as a treatment for the indication. More >

Looking Back at 2020, Looking Ahead to 2021: Outstanding Resource Performers
Source: Streetwise Reports  (12/29/20)
Ralph Aldis, portfolio manager at U.S. Global Investors, in this interview with Streetwise Reports, discusses resource companies that have been top performers in 2020 and, looking ahead to 2021, names companies that he expects to outperform. More >

U.S. Gold Shares Trade Higher on Drill Results from Wyoming Gold Property
Source: Streetwise Reports  (12/29/20)
Shares of U.S. Gold Corp. reached a new 52-week high after the company reported drill results from its CK Gold Project in Wyoming that demonstrated 244m of continuous mineralization including 78.3m of 5.708 g/t Au eq from surface at its fourth metallurgical hole. More >

Myovant Shares Rise 25% on $4.2 Billion Development Partnership with Pfizer
Source: Streetwise Reports  (12/28/20)
Shares of Myovant Sciences established a new 52-week high after the company entered into an agreement with Pfizer to jointly develop and commercialize ORGOVYXâ„¢ (relugolix) for advanced prostate cancer and relugolix combination tablet for women's health in the U.S. and Canada. More >

Analyst: Canadian Company's 'Exploration Success Continues' in Mexico
Source: Streetwise Reports  (12/27/20)
Silver Viper Minerals' recent drill results and the impending maiden resource estimate are discussed in a Red Cloud Securities report. More >

Miner Makes New Discovery Near British Columbia Mine
Source: Streetwise Reports  (12/26/20)
Pretium Resources' recent drill results, undervalued exploration potential and 2021 plan are covered in a BMO Capital Markets report. More >

Junior Miner Developing Two Heap Leach Projects in California
Source: The Critical Investor for Streetwise Reports  (12/24/20)
The Critical Investor looks into the technicals for "undervalued" KORE Mining, including the heap leach projects and a plan to spin out the FG Gold Project into Karus Gold. More >

Analyst: Differences Between Two Possible COVID-19 Therapies Noteworthy
Source: Streetwise Reports  (12/23/20)
The factors that set Athersys' stem cell product MultiStem apart from a competitor's therapeutic are provided in a Dawson James Securities report. More >